ArticleOncoTargets and therapy2020

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases.

Chenglong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.